ADC Therapeutics SA ADCT

Updated: 9 Aug 2026

NYSE | Biotech | Biotechnology / antibody-drug conjugates

No signal published yet

We already track ADC Therapeutics SA and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow ADC Therapeutics SA free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NYSE
Type
Biotech
Sector
Biotechnology / antibody-drug conjugates
We're already tracking ADC Therapeutics SA — here are the latest events we've registered

Recent News

  • On August 6, 2026, ADC Therapeutics announced it will report its second quarter 2026 financial results on August 13, 2026. Earlier in mid-2026, the company completed patient enrollment in the LOTIS-7 Phase 1b trial and announced a strategic corporate restructuring.

What Firelda Watch includes for ADC Therapeutics SA

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of ADC Therapeutics SA will be delivered in the same format.

Want to follow ADC Therapeutics SA? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow ADC Therapeutics SA free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

ADC Therapeutics SA ADCT
ADC Therapeutics SA — follow and we'll monitor it
Follow ADC Therapeutics SA free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.